Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PepCan in Head and Neck Cancer Remission
NCT03821272Phase 2Completed
- Sponsor
- University of Arkansas
- Start
- Nov 2019
- Primary completion
- Feb 2025
- Modality
- Peptides, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of PepCan in head and neck cancer (HNC), sponsored by University of Arkansas. Started Nov 2019; status: completed.
02
Drugs
PepCan
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on NCT03821272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03821272.